Please assess the completion status of the following clinical trial:

Trial Title: Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male (or transgender male person at birth)~* At least 18 years old~* HIV-seronegative~* Having had at least one anal sex episode with another man within the previous 6 months~* Having at least one of the following criteria:~  * Have a sexual partner (male or female) infected with HIV without evidence of virological suppression~ * Have had anal or vaginal sex episodes without condoms with more than one partner within the previous 6 months~ * Have had a sexually-transmitted infection (STI) within the previous 6 months (syndromic or biological approach, or mentioned by the participant)~ * Have received post-exposure prophylaxis for HIV within the previous 6 months~ * Wishing to reinforce its means of prevention through the use of PrEP~* Accepting to participate in the study and signing the informed consent form~Exclusion Criteria:~* Clinical manifestations suggesting a primary HIV infection~* Recent probable HIV exposure~* Creatinine clearance \<60 mL/min calculated according to the Cockroft \& Gault formula~* Positive or undetermined HBsAg~* Allergy or contraindication to any of the components of PrEP~* Participation in another biomedical and/or behavioral study on HIV or STIs (excluding CohMSM)~* Disability of the person making it difficult, if not impossible, to participate in the study or understanding of the information given to him~* Predictable non-compliance with the protocol (geographical distance, non-compliance with monitoring or other reasons)

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- HIV prevention package including PrEP (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).